Renal replacement therapy (RRT) for acute kidney injury (AKI), albumin dialysis, or plasma exchange for acute-on-chronic liver failure (ACLF) or acute liver failure (ALF) can be used to temporarily support failing organs. This evidence concerns the gene ALB and acute kidney injury.